Drug Approval | November 13, 2024
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
Lupin's R&D teams are working on products with a near-zero global warming potential propellant
Union Government will provide a health cover of Rs. 5 lakh to any elderly person above 70 years of age
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Subscribe To Our Newsletter & Stay Updated
